Phenomenology of N,N-dimethyltryptamine use: A thematic analysis

Journal of Scientific Exploration

Volumn 22, Issue 3, 2008, Pages 359-370

  Cott, Christopher ^a   Rock, Adam ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

N,N dimethyltryptamine; Phenomenology; Thematic analysis

Indexed keywords

COMPUTER SYSTEM RECOVERY;

CHEMICAL CLASSES; EXPERIMENTAL RESEARCHES; N,N-DIMETHYLTRYPTAMINE; ONLINE SURVEYS; PHENOMENOLOGY; QUALITATIVE STUDIES; THEMATIC ANALYSIS;

DILATOMETERS;

EID: 54249159606     PISSN: 08923310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bickel, P., Dittrich, A., & Schoepf, X. X. (1976). Altered states of consciousness induced by N,N-dimethyltryptamine (DMT). Pharmakopsychiatr Neuropsychopharmakol, 9(5), 220-225.
2. Ciprian-Ollivier, J., & Cetkovich-Bakmas, M. G. (1997). Altered consciousness states and endogenous psychoses: A common molecular pathway? Schizophrenia Research, 28, 257-265.
3. Dittrich, A. (1998). The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiat, 31, 80-84.
4. Elite, O. (1998). The experience of being silent. In Valle, R. (Ed.), Phenomenological Inquiry in Psychology (pp. 309-320). Plenum Press.
5. Furst, P. (1972). Flesh of the Gods: The Ritual Use of Drugs in the Primitive Origins of Religion. Praeger.
6. Gifford-May, D., & Thompson, N. L. (1994). "Deep states" of meditation: Phenomenological reports of experience. Journal of Transpersonal Psychology, 26, 117-138.
7. Giorgi, A. (2000). Phenomenology and Psychological Research. Duquesne University Press.
8. Greyson, B. (2006). Near-death experiences and spirituality. Zygon, 41, 393-414.
9. Hanson, D., & Klimo, J. (1998). Toward a phenomenology of synchronicity. In Valle, R. (Ed.), Phenomenological Inquiry in Psychology (pp. 281-307). Plenum Press.
10. Harner, M. J. (1973). The sound of rushing water. In Harner, M. J. (Ed.). Hallucinogens and Shamanism (pp. 15-27). Oxford University Press.
11. Jacob, M. S., & Presti, D. E. (2004). Endogenous psychoactive tryptamines reconsidered: An anxiolytic role for dimethyltryptamine. Medical Hypotheses, 64, 930-937.
12. Kelly, E. W. (200 1). Near-death experiences with reports of meeting deceased people. Death Studies, 25, 229-249.
13. Krippner, S. (2002). Conflicting perspectives on shamans and shamanism: Points and counterpoints. American Psychologist, 57, 962-977.
14. Lange, R., Greyson, B., & Houran, J. (2004). A Rasch scaling validation of a "core" near-death experience. British Journal of Psychology, 95, 161-177.
15. Liester, M. B., Grob, C. S., Bravo, G. L., & Walsh, R. N. (1992). Phenomenology and sequelae of 3,4-metbylenedioxymethamphetamine use. Journal of Nervous and Mental Disease, 180, 345-352.
16. Manske, R. H. F. (1931). A synthesis of the methyl-tryptamines and some derivatives. Canadian Journal of Research, 5, 592-600.
17. Matsu-Pissot, C. (1998). On the experience of being unconditionally loved. In Valle, R. (Ed.), Phenomenological Inquiry in Psychology (pp. 321-334). Plenum Press.
18. McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of Ayahuasca: Rationale and regulatory challenges. Pharmacology & Therapeutics, 102, 111-129.
19. McKenna, T. (1991). The Archaic Revival. HarperCollins.
20. McNair, D. M., Lorr, M., & Droppleman, L. F. (1992). POMS: Profile of Mood States. Multi-Health Systems.
21. Pekala, R. J. (1991). Quantifying Consciousness: An Empirical Approach. Plenum Press.
22. Rabin, R. A., Regina, M., Doat, M., & Winter, J. C. (2002). 5-HT2A receptor-stimulated phosphomositide hydrolysis in the stimulus effects of hallucinogens. Pharmacology Biochemistry and Behaviour, 72, 29-37.
23. Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., Callaway, J. C., & Barbanoj, M. J. (200 1). Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology, 154, 85-95.
24. Rock, A. J. (2006). Phenomenological analysis of experimentally induced visual mental imagery associated with shamanic journeying to the lower world. International Journal of Transpersonal Studies, 25, 45-55.
25. Rock, A. J., Beischel, J., & Schwartz, G. E. (in press). Thematic analysis of research mediums' experiences of discarnate communication. Journal of Scientific Exploration.
26. Siskind, J. (1973). Visions and cures among the Sharanahua. In Hamer, M. J. (Ed.), Hallucinogens and Shamanism (pp. 28-39). Oxford University Press.
27. Strassman, R. J. (1996). Human psychopharmacology of N,N-dimethyltryptamine. Behavioural Brain Research, 73, 121-124.
28. Strassman, R. J. (2001). DMT: The Spirit Molecule. Park Street Press.
29. Strassman, R. J. (2008). Personal communication.
30. Strassman, R. J., & Qualls, C. R. (1994). Dose-response study of N,N-dimethyltryptamine in humans: I Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry, 51, 85-97.
31. Strassman, R. L, Qualls, C. R., Uhlenhuth, E. H., & Kellner, R. (1994). Dose-response study of N,N-dimethyltryptamine in humans: H Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry, 51, 98-108.
32. Walsh, R. (1989). What is a shaman? Definition, origin and distribution. Journal of Transpersonal Psychology, 21, 1-11.
33. Weiss, G. (1973). Shamanism and priesthood in the light of the Campa Ayahuasca ceremony. In Harner, M. J. (Ed.). Hallucinogens and Shamanism (pp. 15-27). Oxford University Press.
34. West, T. (1998). The experience of being with a dying person. In Valle, R. (Ed.), Phenomenological Inquiry in Psychology (pp. 359-371). Plenum Press.